Advertisement
Articles
Subscribe to Drug Discovery & Development Articles

The Lead

Promising Malaria and Dengue Vaccines Will Not Defeat Diseases

May 20, 2015 | by Christopher J. Pace, Ph.D., GlobalData Managing Analyst, Infectious Diseases | Comments

Some industry pundits rightfully question the modest protective efficacies of CYD-TDV and RTS,S/AS01. Read more...

TOPICS:
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Beyond Pills: Designing a Winning Delivery Strategy for the New Era of Biologics

July 31, 2015 9:32 am | by Nurry Hong, Managing Director; Sue St. Sure, Managing Director; and Max Cambras, Life Sciences Expert, Manager, of L.E.K. Consulting | Comments

With the rise of biologics, drug delivery presents new challenges as many companies are still taking a fragmented approach, resulting in delayed (or suboptimal) product launches and life cycle management. The problem is that it’s extremely difficult, if not impossible, to fix drug delivery challenges after the fact, so companies need a clear strategy in advance. Read more...

TOPICS:

Type 2 Diabetes Mellitus Treatment Market Value Will Reach $39B by 2021

July 31, 2015 9:31 am | by Fiona Chisholm, Associate Analyst, GBI Research | Comments

More recently approved drug classes have already achieved considerable uptake and are expected to increase their market share over the forecast period. Read more...

TOPICS:

Teva's $40.5B Allergan Acquisition Likely to Yield Substantial Returns

July 31, 2015 8:40 am | by Gianfranco Zeppetelli, Deals Analyst, GlobalData | Comments

Teva's bid for Allergan’s generics business illustrates that it has given up on its pursuit of rival Mylan NV. Read more...

TOPICS:
Advertisement

Gene Therapy Makes Near-Blind Patients See by Strengthening Neural Connections

July 29, 2015 10:13 am | by Cynthia Fox, Science Editor | Comments

Gene therapy restored vision to blind patients by strengthening visual pathways from the retina, through the brain’s white matter, into the brain’s visual cortex, says a report in Science Translational Medicine. Read more...

TOPICS:

Four-Pronged Flu Prevention

July 29, 2015 9:39 am | by Lindsay Hock, Editor | Comments

Now, (July/August) is the time frame when flu vaccines start to be delivered to protect the public for next year. Yet, the road to an efficient vaccine is a difficult one. Just as with any virus, influenza mutates in its genetic material, potentially causing changes in the strains present each year. Read more...

TOPICS:

Roche's Atezolizumab Could Spur Long-Awaited Bladder Cancer Treatment Innovation

July 29, 2015 8:40 am | by Cai Xuan, Ph.D., Oncology and Hematology, GlobalData | Comments

This observation opens up a market for companion biomarker tests that can be used to identify patients who would likely benefit from PD-1/PD-L1-targeted therapies. Read more...

TOPICS:

Quality Standards for Pharma

July 29, 2015 8:37 am | by Lindsay Hock, Editor | Comments

 Little do we think of the testing behind the medications prescribed to us that improve the quality of our lives. Yet, stringent testing is needed for any pharmaceutical or health care product to hit the shelves of your local convenience store. Read more...

TOPICS:

AACC 2015: Research Expanded Upon for New Rapid Response Ebola Test

July 27, 2015 10:40 am | by Ryan Bushey, Associate Editor | Comments

The test is able to diagnose the virus in 15 minutes. Read more...

TOPICS:
Advertisement

U.S., China Will Drive Cancer Companion Diagnostics Market Value to $670M by 2020

July 22, 2015 8:31 am | by Andrew S. Thompson, Ph.D., Senior In Vitro Diagnostics Analyst, GlobalData | Comments

Other significant drivers of cancer companion diagnostics market growth include increasing disease incidence, accelerating demand for targeted therapies and economic pressures to develop maximally efficient treatments. Read more...

TOPICS:

Aspirin’s Myriad Effects on Breast Cancer

July 22, 2015 8:20 am | by Cynthia Fox, Science Editor | Comments

A July Laboratory Investigation report found aspirin may render the environment of cancer stem cells, which can linger post-chemo, hostile to replication. Aspirin may also ward off breast cancer prophylactically, according to the study led by Sushanta Banerjee, Ph.D., research director of the Cancer Research Unit at the Kansas City (Mo.) Veterans Affairs Medical Center. Read more...

TOPICS:

HerpV, GEN-003 Will Drive Genital Herpes Treatment Market Growth to 2023

July 21, 2015 8:32 am | by Daian Cheng, Ph.D., Infectious Disease Analyst, GlobalData | Comments

The low price of generic drugs not only will limit the sales of existing treatment, it also poses an entry barrier for new therapies. Read more...

TOPICS:

Taiwan's Pharmaceutical Market Value will Hit $8.4B by 2020

July 15, 2015 2:32 pm | by Joshua Owide, Director of Healthcare Industry Dynamics, GlobalData | Comments

This growth will happen despite diplomatic tensions. Read more...

TOPICS:

Wider Use of Statins Has Positive Results, Say New Studies

July 15, 2015 1:16 pm | by Ryan Bushey, Associate Editor | Comments

The Journal of the American Medical Association (JAMA) published two new studies on Tuesday that support controversial cholesterol guidelines. Read more...

TOPICS:

Gene Therapy Makes Deaf Mice Hear

July 15, 2015 12:07 pm | by Cynthia Fox, Science Editor | Comments

For the first time, gene therapy partially restored hearing to young mice who were born stone-deaf due to a human deafness gene mutation. Read more...

TOPICS:

Anti-hypertensive Therapeutics Market Value in Asia Pacific to Approach $20B by 2021

July 15, 2015 8:40 am | by Aswini Nath, Analyst, GBI Research | Comments

Japan is the largest anti-hypertensive therapy market among the four APAC countries, valued at $8.1 billion in 2014 and representing 52 percent of the region’s anti-hypertensive treatment space. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading